Check Cap Ltd (NASDAQ:CHEK) is scheduled to post its quarterly earnings results on Thursday, October 20th. Analysts expect Check Cap to post earnings of ($0.19) per share for the quarter.

Shares of Check Cap Ltd (NASDAQ:CHEK) opened at 1.84 on Tuesday. The company’s market cap is $22.55 million. Check Cap Ltd has a one year low of $0.97 and a one year high of $3.72. The company’s 50-day moving average price is $2.00 and its 200 day moving average price is $1.99.

CHEK has been the subject of a number of research analyst reports. Maxim Group upped their price objective on shares of Check Cap from $6.00 to $11.00 and gave the company a “buy” rating in a research report on Monday, August 1st. Zacks Investment Research lowered shares of Check Cap from a “buy” rating to a “hold” rating in a research report on Wednesday, July 20th.

About Check Cap

Check-Cap Ltd. (Check-Cap) is a clinical-stage medical diagnostics company. The Company is engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The Company’s system consists of main components, such as ingestible scanning capsule; Capsule Positioning System (CPS), a recorder worn on the patient’s back, and a personal computer (PC)-based work station for data reconstruction and image processing.

5 Day Chart for NASDAQ:CHEK

Receive News & Ratings for Check Cap Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Check Cap Ltd and related companies with's FREE daily email newsletter.